Cargando…

Matching the Decay Half-Life with the Biological Half-Life: ImmunoPET Imaging with (44)Sc-Labeled Cetuximab Fab Fragment

[Image: see text] Scandium-44 (t(1/2) = 3.9 h) is a relatively new radioisotope of potential interest for use in clinical positron emission tomography (PET). Herein, we report, for the first time, the room-temperature radiolabeling of proteins with (44)Sc for in vivo PET imaging. For this purpose, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakravarty, Rubel, Goel, Shreya, Valdovinos, Hector F., Hernandez, Reinier, Hong, Hao, Nickles, Robert J., Cai, Weibo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275156/ https://www.ncbi.nlm.nih.gov/pubmed/25389697 http://dx.doi.org/10.1021/bc500415x

Ejemplares similares

(44)Sc: An Attractive Isotope for Peptide-Based PET Imaging
por: Hernandez, Reinier, et al.
Publicado: (2014)

On the half-life of $^{44}Ti$
por: Norman, E B, et al.
Publicado: (1996)

CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody
por: Hernandez, Reinier, et al.
Publicado: (2016)

Site-Specific (68)Ga Radiolabeling of Trastuzumab Fab via Methionine for ImmunoPET Imaging
por: Yue, Thomas T. C., et al.
Publicado: (2023)

ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer
por: England, Christopher G., et al.
Publicado: (2016)

Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin Fv domain: An investigation into the correlation between affinity and serum half-life
por: Adams, Ralph, et al.
Publicado: (2016)

Single chain Fab (scFab) fragment
por: Hust, Michael, et al.
Publicado: (2007)

Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
por: Wei, Weijun, et al.
Publicado: (2020)

Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications
por: Fu, Ruisi, et al.
Publicado: (2018)

Imaging PD-L1 Expression with ImmunoPET
por: Truillet, Charles, et al.
Publicado: (2017)

Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding
por: Davé, Emma, et al.
Publicado: (2016)

A Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties
por: Unverdorben, Felix, et al.
Publicado: (2015)

Generation and Screening of Monoclonal Antibodies for ImmunoPET Imaging of IGF1R in Prostate Cancer
por: Hong, Hao, et al.
Publicado: (2014)

ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2022)

Visualizing Galectin-3 Binding Protein Expression with ImmunoPET
por: Keinänen, Outi, et al.
Publicado: (2023)

Editorial: ImmunoPET imaging in disease diagnosis and therapy assessment
por: Mulero, Francisca
Publicado: (2023)

Production of single chain Fab (scFab) fragments in Bacillus megaterium
por: Jordan, Eva, et al.
Publicado: (2007)

Nanobody: The “Magic Bullet” for Molecular Imaging?
por: Chakravarty, Rubel, et al.
Publicado: (2014)

Ytterbium-175 half-life determination
por: Durán, M Teresa, et al.
Publicado: (2021)

The influence of electron screening on half-lifes
por: Ruprecht, G, et al.
Publicado: (2006)

Commentary on Pharmacologically Meaningful Half‐Life
por: Holford, Nick
Publicado: (2022)

DESY: Half HERA at 4.4K
Publicado: (1990)

Pre-clinical Imaging of Invasive Candidiasis Using ImmunoPET/MR
por: Morad, Hassan O. J., et al.
Publicado: (2018)

ImmunoPET in Multiple Myeloma—What? So What? Now What?
por: Bailly, Clément, et al.
Publicado: (2020)

Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice
por: Meyblum, Louis, et al.
Publicado: (2023)

Half Life - The divided life of Bruno Maximovitch Pontecorvo
por: Close, Frank
Publicado: (2016)

Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life Products
por: Tortella, Bartholomew J., et al.
Publicado: (2018)

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia
por: Versloot, Olav, et al.
Publicado: (2022)

Development of [(89)Zr]Zr-hCD103.Fab01A and [(68)Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET
por: Fan, Xiaoyu, et al.
Publicado: (2023)

Half-and-half nails
por: Gandhi, K., et al.
Publicado: (2014)

Half and half nails
por: Neild, G. H., et al.
Publicado: (2011)

Half and half nail
por: Avhad, Ganesh, et al.
Publicado: (2014)

Half-and-Half Palatoplasty
por: Han, Hyun Ho, et al.
Publicado: (2014)

ImmunoPET to help stratify patients for targeted therapies and to improve drug development
por: Kraeber-Bodere, Françoise, et al.
Publicado: (2016)

Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas
por: de Lucas, A. G., et al.
Publicado: (2016)

ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience
por: de Lucas, Ángel García, et al.
Publicado: (2023)

(89)Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo
por: Alizadeh, Elahe, et al.
Publicado: (2021)

Half-life of polybrominated biphenyl in human sera.
por: Rosen, D H, et al.
Publicado: (1995)

Alpha Decay Half-Life of Bismuth Isotopes
por: Tavares, O A P, et al.
Publicado: (2004)

Chimeric antibodies with extended half-life in ferrets
por: Nesspor, Thomas C, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bem1dqs54tda5ju3orosn59946